Millipore Sigma Vibrant Logo
Attention: We have moved. Merck Millipore products are no longer available for purchase on MerckMillipore.com.Learn More

03-104 RIPAb+ CUGBP1 - RIP Validated Antibody and Primer Set

03-104
10 assays  10 assays per set. Recommended use: ~5 μg of antibody per RIP (dependent upon biological context).
Purchase on Sigma-Aldrich

特卖

概述

Replacement Information

重要规格表

Species ReactivityKey Applications
H, M, R, B, Po, RbRIP, IP, WB
Description
Catalogue Number03-104
Brand Family Upstate
Trade Name
  • RIPAb+
  • Upstate
DescriptionRIPAb+ CUGBP1 - RIP Validated Antibody and Primer Set
OverviewRIPAb+ antibodies are evaluated using the RNA Binding Protein Immunoprecipitation (RIP) assay. Each RIPAb+ antibody set includes quantitative RT-PCR control primers (RIP Primers) to biologically validate your IP results by successfully coprecipitating a specific RNA target (where such a specific target is known). The qPCR protocol and primer sequences are provided, allowing researchers to validate RIP protocols when using the antibody in their experimental context. Each set also includes a negative control antibody to ensure specificity of the RIP reaction.
The RIPAb+ CUGBP1 set includes the CUGBP1 (CUG triplet repeat, RNA binding protein 1) antibody, a negative control antibody (normal mouse IgG), and positive qPCR primers which amplify a 100 bp fragment of the human cDNA of JUN. The CUGBP1 and negative control antibodies are supplied in a scalable "per RIP" reaction size and can be used to functionally validate the precipitation of CUGBP1-associated RNA.
Alternate Names
  • CUG triplet repeat, RNA binding protein 1
Background InformationMyotonic dystrophy (MD) is an autosomal dominant neuromuscular disease that is associated with a (CTG)n repeat expansion in the 3'-untranslated region of the myotonin protein kinase (Mt-PK) gene. A (CUG)n oligonucleotides triplet repeat pre-mRNA/mRNA binding protein may play an important role in DM pathogenesis. HeLa cell protein, CUG-BP1, has been purified based upon its ability to bind specifically to (CUG)8 oligonucleotides in vitro. CUG-BP1 is the major (CUG)8 binding activity in normal cells. CUG-BP1 has been identified as isoforms of a novel heterogeneous nuclear ribonucleoprotein (hnRNP), hNab50. The CUG-BP/hNab50 protein is localized predominantly in the nucleus and is associated with polyadenylated RNAs in vivo. In vitro RNA-binding/photocrosslinking studies demonstrate that CUG-BP/hNab50 binds to RNAs containing the Mt-PK 3'-UTR.
References
Product Information
FormatPurified
Control
  • Included negative control mouse IgG antibody and control primers specific for JUN.
PresentationAnti-CUGBP1 (Mouse monoclonal IgG). One vial containing 50 μg of protein G purified mouse IgG1 in 50 µL of 0.014 M phosphate buffer, pH 7.6, 0.175 M NaCl, 0.07% sodium azide, and 30% glycerol. Store at -20°C.

Normal Mouse IgG.
One vial containing 125 μg purified mouse IgG in 125 μL storage buffer containing 0.1% sodium azide. Store at -20°C.

RIP Primers, JUN. One vial containing 75 μL of 5 μM of each primer specific for the cDNA of JUN. Store at -20°C.
FOR: TCG ACA TGG AGT CCC AGG A
REV: GGC GAT TCT CTC CAG CTT CC
Quality LevelMQ100
Applications
ApplicationThis RIPAb+ CUGBP1 -RIP Validated Antibody & Primer Set conveniently includes the antibody & the specific control PCR primers.
Key Applications
  • RNA Binding Protein Immunoprecipitation (RIP)
  • Immunoprecipitation
  • Western Blotting
Application NotesRNA Binding Protein Immunoprecipitation:
RIP lysate prepared from HeLa cells (2 X 107 cell equivalents per IP) were subjected to immunoprecipitation using 5 μg of either a normal mouse IgG or Anti-CUGBP1 antibody and the Magna RIP™ Kit (Cat. # 17-700).
Successful immunoprecipitation of CUGBP1-associated RNA was verified by qPCR using primers for ACTB as a negative control and positive control RIP Primers JUN (Please see figures). Data is presented as percent input of each IP sample relative to input total RNA for each amplicon and RIP sample as indicated.
Please refer to the Magna RIP™ (Cat. # 17-700) or EZ-Magna RIP™ (Cat. # 17-701) protocol for experimental details.

Immunoprecipitation from RIP lysate:
RIP lysate from HeLa cells (2 X 106 cell equivalents per IP) was subjected to immunoprecipitation using 0.5 μg of either a normal mouse IgG or Anti-CUGBP1 antibody. Precipitated proteins were resolved by electrophoresis, transferred to nitrocellulose and probed with anti-CUGBP1 (1.0 μg/mL). Proteins were visualized using One-Step™ IP-Western kit (GenScript Cat. # L00231) (Please see figures).
Biological Information
ImmunogenThe CUGBP1 antibody is made against full-length GST fusion protein corresponding to human CUGBP1, also known as CUG triplet repeat, RNA binding protein 1 or heterogeneous nuclear ribonucleoprotein (hnRNP) hNab50.
HostMouse
SpecificityCUGBP1
IsotypeIgG1κ
Species Reactivity
  • Human
  • Mouse
  • Rat
  • Bovine
  • Pig
  • Rabbit
Antibody TypeMonoclonal Antibody
Entrez Gene Number
Entrez Gene SummaryMembers of the CELF/BRUNOL protein family contain two N-terminal RNA recognition motif (RRM) domains, one C-terminal RRM domain, and a divergent segment of 160-230 aa between the second and third RRM domains. Members of this protein family regulate pre-mRNA alternative splicing and may also be involved in mRNA editing, and translation. This gene may play a role in myotonic dystrophy type 1 (DM1) via interactions with the dystrophia myotonica-protein kinase (DMPK) gene. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq]
Gene Symbol
  • CUGBP1
  • CUGBP
  • NAB50
  • CUG-BP
  • hNab50
  • BRUNOL2
Purification MethodProtein G Purified
UniProt Number
UniProt SummaryFunction: RNA-binding protein implicated in the regulation of several post-transcriptional events. Involved in pre-mRNA alternative splicing, mRNA translation and stability. Mediates exon inclusion and/or exclusion in pre-mRNA that are subject to tissue-specific and developmentally regulated alternative splicing. Specifically activates exon 5 inclusion of cardiac isoforms of TNNT2 during heart remodeling at the juvenile to adult transition. Acts as both an activator and repressor of a pair of coregulated exons: promotes inclusion of the smooth muscle (SM) exon but exclusion of the non-muscle (NM) exon in actinin pre-mRNAs. Activates SM exon 5 inclusion by antagonizing the repressive effect of PTB. Promotes exclusion of exon 11 of the INSR pre-mRNA. Inhibits, together with HNRNPH1, insulin receptor (IR) pre-mRNA exon 11 inclusion in myoblast. Increases translation and controls the choice of translation initiation codon of CEBPB mRNA. Increases mRNA translation of CEBPB in aging liver. Increases translation of CDKN1A mRNA by antagonizing the repressive effect of CALR3. Mediates rapid cytoplasmic mRNA deadenylation. Recruits the deadenylase PARN to the poly(A) tail of EDEN-containing mRNAs to promote their deadenylation. Required for completion of spermatogenesis. Binds to (CUG)n triplet repeats in the 3'-UTR of transcripts such as DMPK and to Bruno response elements (BREs). Binds to muscle-specific splicing enhancer (MSE) intronic sites flanking the alternative exon 5 of TNNT2 pre-mRNA. Binds to AU-rich sequences (AREs or EDEN-like) localized in the 3'-UTR of JUN and FOS mRNAs. Binds to the IR RNA. Binds to the 5'-region of CDKN1A and CEBPB mRNAs. Binds with the 5'-region of CEBPB mRNA in aging liver.
Subunit structure: Component of an EIF2 complex at least composed of CELF1/CUGBP1, CALR, CALR3, EIF2S1, EIF2S2, HSP90B1 and HSPA5. Associates with polysomes By similarity. Interacts with HNRNPH1; the interaction in RNA-dependent. Interacts with PARN.
Subcellular location: Nucleus. Cytoplasm. Note: RNA-binding activity is detected in both nuclear and cytoplasmic compartments.
Tissue specificity: Ubiquitous.
Induction: Up-regulated in myotonic dystrophy pathophysiology (DM).
Post-translational modification: Phosphorylated. Its phosphorylation status increases in senescent cells.
Sequence similarities: Belongs to the CELF/BRUNOL family.
Contains 3 RRM (RNA recognition motif) domains.
Molecular Weight50 kDa
Physicochemical Information
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Quality AssuranceRNA Binding Protein Immunoprecipitation:
RIP lysate prepared from HeLa cells (2 X 107 cell equivalents per IP) were subjected to immunoprecipitation using 5 µg of either a normal mouse IgG, or Anti-CUGBP1 antibody and the Magna RIP™ RNA-Binding Protein Immunoprecipitation Kit (Cat. # 17-700).
Successful immunoprecipitation of CUGBP1-associated RNA was verified by qPCR using RIP Primers JUN (Please see figures).
Please refer to the Magna RIP™ (Cat. # 17-700) or EZ-Magna RIP™ (Cat. # 17-701) protocol for experimental details.
Usage Statement
  • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Storage and Shipping Information
Storage ConditionsStable for 1 year at -20°C from date of receipt. Handling Recommendations: Upon first thaw, and prior to removing the cap, centrifuge the vial and gently mix the solution. Aliquot into microcentrifuge tubes and store at -20°C. Avoid repeated freeze/thaw cycles, which may damage IgG and affect product performance.
Packaging Information
Material Size10 assays
Material Package10 assays per set. Recommended use: ~5 μg of antibody per RIP (dependent upon biological context).
Transport Information
Supplemental Information
Specifications
Global Trade Item Number
产品目录编号 GTIN
03-104 04053252468421

Documentation

RIPAb+ CUGBP1 - RIP Validated Antibody and Primer Set 分析证书

标题批号
RIPAb+ CUGBP1, clone 3B1 - 2002735 2002735
RIPAb+ CUGBP1, clone 3B1 - 3190989 3190989
RIPAb+ CUGBP1, clone 3B1 - 3389024 3389024
RIPAb+ CUGBP1, clone 3B1 - 3537182 3537182
RIPAb+ CUGBP1, clone 3B1 - 3708823 3708823
RIPAb+ CUGBP1, clone 3B1 - 3849695 3849695
RIPAb+ CUGBP1, clone 3B1 - 4119842 4119842
RIPAb+ CUGBP1, clone 3B1 - NG1922979 NG1922979
RIPAb+ CUGBP1, clone 3B1 - NRG1682632 NRG1682632
RIPAb+ CUGBP1, clone 3B1 -2519834 2519834

参考

参考概述应用公共医疗ID
RNA-binding proteins regulate the expression of the immune activating ligand MICB.
Nachmani, D; Gutschner, T; Reches, A; Diederichs, S; Mandelboim, O
Nature communications  5  4186  2014

显示摘要
Western Blotting24924487 24924487
Sulfated polysaccharides from red microalgae have antiinflammatory properties in vitro and in vivo.
Mary S Matsui,Neelam Muizzuddin,Shoshana Arad,Kenneth Marenus
Applied biochemistry and biotechnology  104  2003

显示摘要
12495202 12495202
Immobilization of glutaryl-7-aminocephalosporanic acid acylase on silica gel and enhancement of its stability.
Seung Won Park,Jee Won Lee,Suk In Hong,Seung Wook Kim
Applied biochemistry and biotechnology  104  2003

显示摘要
12665670 12665670

相关产品和应用

Related Products

产品目录编号 描述
05-621 Anti-CUGBP1 Antibody, clone 3B1

相关产品,按下列排序: Brand Facete

种类

Life Science Research > Antibodies and Assays > Immunoassays > Immunoprecipitation (IP) > RNA-Binding Protein Immunoprecipitation (RIP) > RIP Validated Antibodies
Life Science Research > Antibodies and Assays > Primary Antibodies
Life Science Research > Protein Detection and Quantification > Immunoassays > Immunoprecipitation (IP) > RNA-Binding Protein Immunoprecipitation (RIP) > RIP Validated Antibodies